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Ethnopharmacological relevance: Copaifera malmei Harms (Fabaceae) is a plant that occurs in the central
region of Brazil, where the plant's leaves infusion is popularly used to treat gastric ulcer and in-
ﬂammatory diseases. This study was aimed to investigate the gastroprotective activity and mode of
action of the plants' leaves infusion in order to establish the scientiﬁc basis for such usage, and to assess
its potential as a source of an anti-ulcer agent.
Materials and methods: Leaves infusion extract of the plant (SIECm) was prepared, freeze dried and
lyophilised. Its qualitative and quantitative phytochemical constituents were investigated using TLC and
HPLC techniques. The safety proﬁle was evaluated on CHO-k1 epithelial cells viability using the Alamar
blue assay, and by acute toxicity test in mice. The gastroprotection and anti-ulcer efﬁcacy of the SIECm
(25, 100 and 400 mg/kg, p.o.) were tested using acute (acidiﬁed ethanol, piroxicam and water restrain
stress), and chronic (acetic acid) experimental ulcer models. The plausible mode of action of the SIECm
was assessed using gastric secretion, gastric barrier mucus, nitric oxide, and its antioxidant (myeloper-
oxidase and catalase) effects in mice and rats. The histopathological analyses of the ulcerated tissues as
well as the extract’s activity on Helicobacter pylori were also investigated.
Results: Phytochemical tests indicated the presence of mainly phytosterols, phenolics and ﬂavonoids. The
SIECm exhibited no cytotoxic effects on the CHO-k1 cells, and no oral acute toxicity in mice. It prevented
against the acute induced ulcerations by enhancing gastroprotection through gastric mucus production,
NO modulation, antioxidant, reduced gastric secretion and enhanced chronic ulcers healing process, as
shown by reduction/prevention of epithelial and vascular damage, in addition to reduction in leucocyte
inﬁltration. The SIECm however did not exhibit activity against H. pylori.
Conclusion: The SIECm is safe, contain useful phytochemicals and exhibited signiﬁcant gastroprotective/
anti-ulcer effects. The results justify its folkloric usage, and provided scientiﬁc evidence of its potential as
a source of new phytodrug to treat gastric ulcers.
& 2015 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Gastric ulcer is a prevalent disorder characterized by mucosal le-
sions caused by an imbalance between aggressive factors (endogenousrved.
tamento de Ciências Básicas
eral de Mato Grosso, Av. Fer-
060-900 Cuiabá-MT, Brazil.
s).or exogenous), and the defensive mechanism factors that work to-
wards the maintenance of mucosal integrity such as mucus, bicarbo-
nate, prostaglandins, blood ﬂow and nitric oxide. The disease often
develops into chronic and recurrent lesion with the attendant risks of
complications that include bleeding, perforation, gastroduodenal ob-
struction, and mortality (Lau et al., 2011).
Despite the current progress made in the treatment of the
disease, some patients do suffer from recurrence or intractability,
indicating that the therapies are not completely effective. There
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these problems, especially with medicinal plant products. These
products have a long and popular usage over the years as valuable
resources in the treatment of gastric ulcer diseases.
The plant genus Copaifera occurs in Brazil, along the Amazon
and its tributaries, and the Cerrado of Central region as well as in
some parts of South America. The genus comprises of 106 species
(www.theplantlist.org), about 20 of which are well known. Their
woods are durable and produces oily liquid (popularly known as
balsam of copaiba) used in folk medicine. Scientiﬁc evaluations
showed that the oil has anti-bactericidal, anthelmintic, analgesic,
anti-inﬂammatory, gastroprotective, trypanocidal and antitumor
activities (Veiga-Júnior et al., 2007).
Copaifera malmei Harms is a plant native to the Central region
of Brazil, and is distributed mainly in the states of Mato Grosso and
Goiás (Oliveira-Filho et al., 2008; Silva, 2010). The plant is dis-
tinguished primarily on the basis of the character of its leaves and
leaﬂets (Dwyer, 1951). It is locally known as ‘pau-d’olinho’, ‘co-
paibinha’ (Oliveira-Filho et al., 2008) ‘pau-d’ óleo’ (Bieski et al.,
2012) or ‘guaranazinho’ (ﬂoradobrasil.jbrj.gov.br). Ethnopharma-
cological studies amongst the inhabitants of some riverine com-
munities in Central Brazil revealed the leaves are used in the form
of infusion for the treatment of inﬂammations and gastric ulcer
diseases. In the locals’ ethnopharmacy, approximately 40 g of the
plant leaves is incubated with hot water, and a cup (150 mL) is
taken twice daily to treat gastric ulcer diseases. The plant’s leaves
infusion is also used for treatment of injury, bronchitis, and kidney
disease. The scientiﬁc bases for the use of C. malmei in the treat-
ment of gastric ulcer disease have not been documented, to the
best of our knowledge.
In this report, we investigated the gastroprotective activity and
mode of action of the leaves infusion extract of C. malmei in order
to generate useful data for its safe and efﬁcacious usage, and also
assessed its potential as an anti-ulcer prototype. The extract’s
constituents were standardised using TLC and HPLC technique,
and its safety investigated on CHO-k1 epithelial cells using the
Alamar blue assay, and acute toxicity test in mice. The gastro-
protective efﬁcacy was evaluated in laboratory mice and rats using
standard ulcer models. Histopathology of the gastric lesions, and
the extract’s activity on H. pylori were also investigated.2. Materials and methods
2.1. Plant material
The plant material was collected in April 2014 at the locality of
Serra Nova Dourada Municipality (11°58′41″ S, 51°34′57″ W), State
of Mato Grosso, Brazil, after obtaining an authorisation (no. 199/
2014) from the ‘Conselho de Gestão do Patrimônio Genético,
Ministério do Meio Ambiente (CGEN/MMA)’, Brazil. The plant was
identiﬁed and authenticated by a taxonomist: Professor Germano
Guarim Neto of the ‘Departamento de Botânica e Ecologia, Uni-
versidade Federal de Mato Grosso’ (UFMT), Cuiabá, Brazil. A vou-
cher specimen (no. 40,754) was deposited at ‘Herbário UFMT’.
2.2. Animals
Adult Wistar rats (180–220 g) and Swiss albino mice (25–30 g)
of both sexes obtained from the ‘Biotério Central’ of UFMT were
used for the studies. The animals were maintained in propylene
cages at 2571 °C in a 12 h dark/12 h light cycle experimental
room, with free access to standard laboratory feeds (Purina©,La-
bina, Goiás, Brasil) and water ad libitum for at least three days
prior to each experiment. A certiﬁcate of approval for the study
(no. 23108.036060/14-5) was granted by the InstitutionalCommittee for Ethics in the Use of Animals (CEUA), UFMT after
reviewing our experimental designs.
2.3. Drugs and reagents
Methanol, rutin, naringin, gallic acid, catechin, morin, luteolin,
stigmasterol, quercetin, kaempferol, benzene, ethyl acetate, formic
acid, carbenoxolone, cimetidine, Nω-nitro-L-arginine methyl ester
hydrochloride (L-NAME), clarithromycin, penicillin, streptomycin,
Dulbecco’s Modiﬁed Eagle’s Medium (DMEM), Mueller Hinton (M-
H) Broth, Bovine serum albumin (BSA), hexadecyl trimethyl am-
monium bromide (HTAB), Foetal Bovine Serum (FBS), and Alcian
blue 8GX were obtained from Sigma-Aldrich Co., St. Louis, MO,
USA. Other chemicals/reagents used were: Ethanol (Tedia Com-
pany, Inc Fairﬁeld, OH, USA), Alamar blue (Invitrogens, Life
Technologies, Grand Island, NY, USA), tetramethylbenzidine (TMB)
(eBioscience Inc., CA, USA) sodium acetate, sodium hydroxide
(Vetecs, Quimica Fina Ltda, RJ, Brazil); Brain-Heart Infusion (BHI)
Broth (Newprov Produtos, Pinhais, PR, Brazil), Foetal Calf Serum
(FCS) (Cultilab, Campinas, SP, Brazil), Sucrose (Dinâmicas, Química
Contemporânea Ltda, Diadema, SP, Brazil); ketamine, and xylazine
(Syntec/R.I. Farmacêutica Ltda, Brasilia, Brazil). All other chemicals,
drugs and reagents used were of analytical grade.
2.4. Cell culture
Chinese hamster ovary (CHO-k1) epithelial cells (BCRJ code:
0069) were obtained from ‘Banco de Células do Rio de Janeiro’, RJ,
Brazil. They were cultured in DMEM, supplemented with 10% FBS,
penicillin (100 U/mL) and streptomycin (100 μg/mL), in an oven
(Quimiss Aparelhos Cientíﬁcos, Diadema – SP, Brazil) at 37 °C in a
humidiﬁed atmosphere with 5% CO2 and 90% air until conﬂuency.
2.5. Microorganism
H. pylori strain ATCC 43504 (vacA and cagA positives) was ob-
tained from Fundação Oswaldo Cruz (FIOCRUZ)’, RJ, Brazil. Stock
cultures were maintained frozen at 30 °C in Skim Milk broth. For
reactivation, the organisms were inoculated on a selective BHI
Broth supplemented with 10% FCS and incubated at 37 °C under
microaerophilic atmosphere of 5–15% O2 and 5–10% CO2, for
3 days.
2.6. Preparation of extracts
Fresh leaves of C. malmei were collected, dried at room tem-
perature, and ground with an electric mill (TE-625 Tecnal, SP,
Brazil). The plant extract was prepared by infusion: a total of 80 g
of the powdered dried material was soaked in 2 L of boiled dis-
tilled water for 15 min; in multiples of 40 g/L to mimic the locals’
ethnopharmacy. The extract was pooled together, ﬁltered, ﬁltrate
kept frozen (Indrels Ultra freezer IULT 335D, Londrina-Parana,
Brazil), lyophilised (Cientifíca-Modelo LJJ02, SP, Brazil) and its
constituents standardised as described in Sections 2.7.1–2.7.3), to
obtain standardised infusion extract of the leaves of C. malmei
(denoted SIECm), which was kept in an amber glass container in a
refrigerator (Brastemp 350 L, SP, Brazil) until use. The SIECm ob-
tained gave the following physicochemical parameters: yield,
7.68% w/w; colour, brown; pH, 4.93 (1 mg/mL at 25 °C); and so-
lubility, greater than 500 mg/mL in distilled water.
2.7. Phytochemical tests
2.7.1. Qualitative evaluation using thin layer chromatography (TLC)
The qualitative phytochemical constituents of SIECm were
evaluated using the TLC method described by Wagner and Bladt
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silica gel plates 0.20 mm Kieselgel 60 Alugrams Xtra Sil G (Ma-
cherey-Nagel GmbH & Co., Düren, Germany); mobile phase, ben-
zene: ethyl acetate: formic acid: methanol (60/30/10/3 v/v); and
revealing: (1) NP/PEG (1% 2-aminoethyl diphenylborinate diluted
in methanol and 5% polyethylene glycol diluted in ethanol), and
(2) citroboric (citric acid: boric acid: methanol (12/12/77 w/v)).
The preparation was then visualized using a UV camera (Vilber
Lourmat CN-15MC, Marne-la-Vallée, France) at 365 nm. The eva-
luation was carried out along with rutin, naringin, gallic acid, ca-
techin, morin, luteolin, quercetin and kaempferol as reference
standards.
2.7.2. Qualitative ﬁngerprint using high performance liquid chro-
matography (HPLC)
The ﬁngerprints proﬁles of SIECm was analysed using a HPLC
instrument (Shimadzus chromatograph-LC-10 Avp series, Japan)
equipped with a pump (LC-10AD), degasser (DGU-14A), UV–vis
detector (SPD-10A), column oven (CTO-10A), manual injector
(Rheodyne loop 20 μL) and integrator (CLASS LC-10A). The se-
paration was carried out by a gradient system, using a reverse-
phase Phenomenex Luna 5 mm C18 column (2504.6 mm2) with
direct-connect C18 Phenomenex Security Guard Cartridges
(43.0 mm2) ﬁlled with similar material as the main column. The
mobile phase consists of: A¼2% formic acid in Milli-Q water; and
B¼2% formic acid in methanol. The system was programmed to
give the following gradients: 0.01–0.10 min, 2.5% B; 0.10–5 min,
25% B; 5–10 min, 45% B; 10–16 min, 45% B; 16–20 min, 80% B; 20–
25 min, 80% B; 25–30 min, 80% B; 30–35 min, 100% B; and 35–
36 min, 100% B. The ﬂow rate was 1 mL/min, UV detection at
280 nm and elution time 37 min. The compounds were identiﬁed
by comparing the retention times of samples and authentic stan-
dards such as gallic acid, rutin, catechin, quercetin and ellagic acid
from (Sigmas).
2.7.3. Quantiﬁcation of total phenolics, total ﬂavonoids and phytos-
terol contents
These were performed using their speciﬁc quantiﬁcation assays
as hereby described. All the quantiﬁcation assays were performed
in triplicate.
Total phenolics content was quantiﬁed using the Folin–Cio-
calteu method, as described by Amorim et al. (2008). Methanolic
solutions (0.2 mL) of SIECm (1 mg/mL, w/v) or the standard used
(gallic acid, 0.1–1.0 mg/mL, w/v) were mixed with Folin–Ciocalteu
reagent (0.5 mL of 10%, v/v), sodium carbonate (1 mL of 75%, w/v)
and Milli-Q water (8.3 mL). The mixture was gently agitated and
kept for 30 min in the dark. The absorbance was measured at
760 nm using a UV–visible spectrophotometer (Biochroms Bio-
wave IIþ , Cambridge, UK). Total phenolics were determined by
interpolation of the absorbance of the samples against a calibra-
tion curve constructed with different concentrations of gallic acid
in Milli-Q water (y¼0.0997xþ0.004 adjusted R2¼0.9956). The
result was expressed as mg gallic acid equivalents (GAE) per gram
of SIECm (mg GAE/g).
The total ﬂavonoids content was quantiﬁed using the method
described by Peixoto-Sobrinho et al. (2008) with slight modiﬁca-
tions. Brieﬂy, 0.5 mL of methanolic solutions of the SIECm
(1 mg/mL w/v) or standard (rutin, 1–10 mg/mL w/v) was mixed
with an aqueous solution of 0.5 mL of 60% acetic acid, 2 mL me-
thanolic solution of 20% pyridine (v/v), 1 mL of 5% aluminium
chloride (w/v) and 6 mL of Milli-Q. The mixture was gently stirred
and kept for 30 min in the dark and its absorbance was then
measured at 420 nm using a spectrophotometer. The total ﬂavo-
noid contents were determined by extrapolating the absorbance of
the samples against a calibration curve constructed with different
concentrations of the rutin standard (y¼0.0215x0.0020 adjustedR2¼0.9978) and expressed as milligrams of rutin equivalents (RE)
per gram of SIECm (mg RE/g).
The total content of phytosterol in SIECmwas determined using
the sulfate phosphate ferric (SPF) method (Lin et al., 2009) with
modiﬁcations. The SPF reagent was prepared as follows: 2.5 g
FeCl3 6H2O was dissolved in 25 mL phosphoric acid, then 10 mL
was taken out and re-dissolved in 100 mL sulfuric acid before the
experiment. Ethanolic solutions (1 mL) of the SIECm (0.2 mg/mL,
w/v) or the standard (stigmasterol, 0.02–0, 1 mg/mL w/v) were
mixed with 1 mL SPF and homogenised. The mixture was stirred
and kept in dark place for 1 h. Subsequently, the absorbance at
550 nmwas measured using a spectrophotometer. The phytosterol
content was determined by extrapolation of the absorbance of the
samples against a calibration curve (y¼77.858xþ0.0442 adjusted
R2¼0.9926) constructed with standard concentrations of stig-
masterol. The result was expressed as milligrams of stigmasterol
equivalents per gram of SIECm (mg SE/g).
2.8. Safety evaluations
2.8.1. Cytotoxicity assay
This assay was performed by adopting the Alamar blue assay
(Nakayama et al., 1997), with slight modiﬁcation. The CHO-k1 cells
(of density 2104 cells/well) were plated on 96-well plates in
200 mL of DMEM and treated with/without SIECm (3.125–
200 mg/mL, serial dilution). Doxorubicin (0.0058–58 mg/mL, serial
dilution) was used as a positive control, while some wells had the
same amount of medium as the negative control. The treatments
were removed after 24 or 72 h incubation and 200 mL of 10% Ala-
mar Blue (resazurin) was added to each well and incubated again
for 5 h. The conversion of resazurin to resoruﬁn by the cells was
measured at 540 nm (oxidised state) and at 620 nm (reduced
state) using microplate spectrophotometer (Multiskan EX, Thermo
Scientiﬁc, Tewksbury, Massachusetts, USA). The cell viability was
expressed as inhibitory concentration at 50% inhibition (IC50
7SEM). IC50 values430 mg/mL were considered non-toxic (Suff-
ness and Pezzuto, 1990).
2.8.2. Acute toxicity test
The acute toxicity proﬁle of SIECm was evaluated in conscious
mice using the method described by Malone (1983). Six mice were
weighed, and a single dose of SIECm (5000 mg/kg, p.o.) was ad-
ministered to each mouse. Another group of mice (n¼3) was given
the vehicle (distilled water, 10 mL/kg) to serve as the control. The
mice were individually observed in an open ﬁeld after the extract
or vehicle administration for signs and symptoms of toxicity at 0,
15, 30, 60 min and after 4, 8, 24, and 48 h; and then once daily for
14 days. All observations were systematically recorded with in-
dividual records kept for each mouse using the Hippocratic qua-
litative/semiquantitative screening and toxicity table adopted from
Malone.
2.9. Evaluation of gastroprotective/anti-ulcer effects
2.9.1. Acidiﬁed ethanol-induced ulcers
This test was performed using the model described by Mizui
and Doteuchi (1983) as modiﬁed (Júnior et al., 2014). After 18 h of
fasting, mice were grouped into ﬁve (n¼6) and treated p.o. with
the vehicle, three dose levels of the extract (25, 100 and 400 mg/
kg), and 100 mg/kg of carbenoxolone to serve as the positive
control. One hour after the treatment, each mouse received 0.3 mL
of 60% ethanol in 0.3 M HCl to induce gastric ulcers. The animals
were then sacriﬁced by cervical dislocation an hour later; and:
(1) their stomachs were removed, opened along the greater cur-
vature, distended between two glass plates for better visualization
and photographed (Khan, 2004). The ulcerated areas were
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gram, NIH, USA), and results expressed in terms of percentage
inhibition of the induced ulceration; (2) ulcerated portions were
carefully cut out for histopathological analysis of ulcerated gastric
tissues as described in Section 2.11.
2.9.2. Nonsteroidal anti-inﬂammatory drugs (NSAIDs)-induced gas-
tric ulcer
In this model, gastric ulcers were induced in rats using pirox-
icam (Puscas et al., 1997; Balogun et al., 2015). Rats were fasted for
24 h, and then treated p.o. with the vehicle, SIECm (25, 100 and
400 mg/kg) and ranitidine (50 mg/kg). One h later, gastric ulcers
were induced with piroxicam (200 mg/kg, p.o.). The rats were
sacriﬁced by cervical dislocation 6 h later and their stomachs were
removed, opened along the greater curvature, distended between
two glass plates for better visualization, and photographed. The
lengths of lesions were measured using Image J 1.48v, and the
lesion index expressed as the sum of all lesions in each stomach.
2.9.3. Water restraint-stress (WRS)-induced ulcer
The model described by Takagi et al. (1964) as modiﬁed (Yes-
ilada et al., 2014) was adopted for this assay. The rats were fasted
for 20 h with water ad libitum, then divided into ﬁve groups (n¼6)
and treated p.o. with vehicle, three dose levels of the extract (25,
100 and 400 mg/kg), and 100 mg/kg of Cimetidine. Thirty min
after the treatments, each rat was individually immobilised in a
restraining cage and immersed vertically up to the xiphoid process
level in a water- bath maintained at 1971 °C; and they remained
in that position for 7 h. After this period, the animals were eu-
thanized, their stomachs removed, the length of each lesion was
measured using Image J 1.48v, summed up and expressed in terms
of ulcerated area (mm2).
2.9.4. Acetic acid-induced chronic ulcers
The potential effect of SIECm on ulcer healing was tested using
the acetic acid-induced method (Takagi et al., 1969; Martins et al.,
2014). The mice were ﬁrst acclimatized in the laboratory by un-
dergoing a period of adaptation against stress involved in the
study as follows: the animals received distilled water (10 mL/kg)
given orally; followed by food for 2 h per day for three days. They
were then fasted for 12 h prior to the commencement of the ex-
periment. On day one (D1), the mice were anaesthetised with
solution of a mixture of ketamine/xylazine (40/50 mg/kg, i.p.).
Under the anaesthesia, the abdomen was opened by a midline
incision below the xiphoid process, stomach exposed and gastric
ulcer induced by carefully injecting 15 mL of 30% acetic acid with a
micro syringe/needle in the submucosal layer, glandular part of
the anterior portion of the stomach wall, keeping pressed the
application site for a moment. The stomach and the abdominal
wall were then bathed with sterile 0.9% saline (to avoid ad-
herence), and the incisions were closed by interrupted sutures. A
sham group was operated upon; in which 15 mL of sterile saline
was injected (in place of acetic acid) and included in the experi-
ment for comparison. All animals were then housed in poly-
propylene cages to recover from anaesthesia, and received only
water on D1.
Two days after the surgery (D3), the mice were grouped into
ﬁve (n¼6) and treated p.o. twice daily with vehicle, SIECm (12.5,
50 and 200 mg/kg), and Cimetidine (50 mg/kg) at 08:00 and
16:00 hours for 7 days (D3–D9). The sham operated group received
the vehicle throughout these treatment regimens. On D10, the mice
were sacriﬁced under anaesthesia, their stomachs removed,
opened along the greater curvature and the macroscopic ulcer
lesion area (width length) were evaluated (in mm2) with the aid
of a digital calliper (DIGIMESS: 90173020, SP, Brazil).2.10. Evaluation of gastroprotective mechanism of action
2.10.1. Effect on gastric secretion
This assay was carried out in rats using the Shay et al. (1954)
pylorus-ligation gastric ulceration method as modiﬁed by Singh
et al. (2013). The rats were acclimatised for 3 days, and fasted for
24 h with water ad libitum prior to the experiment. They were
then anaesthetised i.p. with a mixture of ketamine (60 mg/kg) and
xylazine (7 mg/kg), laparotomy performed, the pylorus ligated and
the rats treated intraduodenally with the vehicle (distilled water,
10 mL/kg), SIECm (12.5, 50 and 200 mg/kg) and cimetidine
(50 mg/kg). Six hours later, the animals were sacriﬁced by cervical
dislocation; the abdomen opened, another ligature placed around
the oesophagus close to the diaphragm, stomach removed, the
gastric contents collected and centrifuged at 2500 g for 10 min
(ALC 4239R, ALC International SrI, Cologno Monzese, Italy). After
that, the total gastric-juice volume (mL) was measured, 0.5 mL was
taken out of it, and made up to 5 mL with distilled water; from
which the free acidity was determined using a pH metre (MS
Tecnopon Instrumentação, Piracicaba – SP, Brazil) and total acidity
(mEq [Hþ]/mL) estimated by titration to pH 7.0 with 0.01 N NaOH
using 1% phenolphthalein as indicator.
2.10.2. Protective effect on gastric barrier mucus
This assay was carried out in mice by adopting the method
described by Corne et al. (1974) with slight modiﬁcation. The mice
were fasted for 18 h, and then grouped into ﬁve groups (n¼6).
Group 1 was treated with the vehicle, Groups 2–4 with three dose
levels of SIECm (25, 100 and 400 mg/kg, p.o.), while Group 5 re-
ceived 100 mg/kg, p.o. of carbenoxolone (100 mg/kg). Each mouse
was given 0.3 mL of 60% ethanol in 0.3 M HCl, 1 h after the treat-
ments. The animals were sacriﬁced by cervical dislocation 1 h later
and the glandular segments of their stomachs were removed,
weighed, and immediately placed in 10 mL solution of 0.02% Al-
cian blue 8GX in 0.16 M sucrose solution (that was dissolved in
0.05 M sodium acetate buffer, adjusted to pH 5.3 with HCl) and
incubated at 2071 °C for 24 h. After which the mixture was
centrifuged at 2500 g for 10 min (ALC 4239R, ALC International
SrI, Cologno Monzese, Italy), and absorbance of the supernatant of
each sample measured at 598 nm using a UV–visible Spectro-
photometer (Spectronic GENESYS 5, Thermo Electron Coorp., Ma-
dison, USA). The concentration of Alcian blue was calculated by
linear regression with a calibration curve obtained from standard
serial dilutions of different concentrations of the dye
(y¼0.0147xþ0.1318 adjusted R2¼0.9812), and results were ex-
pressed in mg of Alcian blue/g of tissue.
2.10.3. Assessment of the role of nitric oxide (NO) in the gastro-
protective action
The role of NO in the gastroprotective action of SIECm was
assessed using the method described by Matsuda et al. (1999) with
modiﬁcations using suboptimal doses of L-NAME (nitric oxidase
synthases inhibitor) and carbenoxolone. Mice were fasted for 18 h
and grouped into ﬁve groups (n¼6). They were ﬁrst pre-treated p.
o. with 10 mg/kg of L-NAME, and 30 min later, the mice were
treated with vehicle (10 mL/kg, p.o.), SIECm (25, and 100 mg/kg) or
carbenoxolone (30 mg/kg). One h after the treatments, all the mice
were given 0.3 mL of acidiﬁed ethanol (60% ethanol in 0.3 M HCl)
to induced gastric ulceration; and 1 h after the ulcer induction, the
animals were sacriﬁced, their stomachs removed and the per-
centage inhibition of gastric ulceration was evaluated as men-
tioned in Section 2.9.1.
2.10.4. Evaluation of antioxidant activity
Gastric ulcerations were induced in rats using the WRS-in-
duced model described in Section 2.9.2, but in this case, a sham
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were removed, opened along the greater curvature, washed, and
the glandular portion of the stomachs was cut into two, weighed
and placed into falcon tubes and stored at 80 °C in a biofreezer
(Indrels Ultra freezer IULT 335D) for the CAT (Section 2.10.4.1) and
MPO (Section 2.10.4.2) assays.
2.10.4.1. Determination of Catalase (CAT) activity. The method de-
scribed by Aebi (1984) was used with modiﬁcation. The weighed
glandular portion of the stomach (Section 2.10.4) was homo-
genised (MA120, Marconi–Equipamentos, SP, Brazil) with phos-
phate buffer (pH 7) and centrifuged at 11,180 g for 10 min at 4 °C.
A solution of 1 mM H2O2 (2 mL) in 50 mM phosphate buffer pH
7.0 was put into a quartz cuvette, 20 mL of sample added; and
reading taken immediately at 240 nm (A240¼0.380–0.400), and at
every minute for 4 min using a UV–visible Spectrophotometer. The
absorbance values were extrapolated from a curve obtained from
standard concentrations of H2O2 in the 50 mM phosphate buffer
solution (y¼6.7423x – 0.0079 adjusted R2¼0.9959). Protein values
were extrapolated from a curve of standard concentration of BSA
(y¼0.0007xþ0.0347 adjusted R2¼0.9751). The results were ex-
pressed in μMH2O2/min/g protein.
2.10.4.2. Determination of Myeloperoxidase (MPO) action. The MPO
activity was determined using the method described by Schier-
wagen et al. (1990) with modiﬁcation. The other glandular portion
of the stomach (Section 2.10.4) was homogenised on ice in phos-
phate buffer (0.2 M, pH 6.6). Then, samples were centrifuged at
9000 g for 10 min at 4 °C. The supernatant was discarded and
the pellet re-suspended in phosphate buffer (0.08 M, pH 6.6) with
HTAB (0.05%) and sonicated for 30 sec. After which the samples
were re-centrifuged at 11,000 g for 20 min at 4 °C. In 96-well
plates, 30 uL of the supernatant, 220 mL of a solution containing a
mixture of: 100 mL of 80 mM phosphate buffer, 85 mL of 22 mM
phosphate buffer and 15 mL of 0.017% H2O2. The reaction was
started by adding 20 mL of TMB, and the sample incubated for
3 min at 37 °C. The reaction was quenched with 30 mL of 1 M
H2SO4 and the sample absorbance were read using a microplate
reader (Biochrom EZ Read 400, Cambridge, UK) at 450 nm. The
absorbance values were extrapolated from a curve of standard
concentration (y¼0.0007xþ0.0347 adjusted R2¼0.9751). The en-
zyme activity was calculated and the results were expressed as U/g
tissue.
2.11. Histopathological analysis
The ulcerated gastric tissues obtained (in Section 2.9.1) were
subjected to histopathological analysis. The tissues were ﬁxed in
4% buffered paraformaldehyde solution, and dehydrated with
mixtures of increasing grades of ethanol, clariﬁed in xylene using a
tissue processor (MTP-SLEE, Mainz, Germany) and embedded in
parafﬁn. After processing, two sections of tissues were made from
each block using a Hyrax M60 microtome (Carl Zeiss, Oberkochen,
Germany) and stained with haematoxylin/eosin (HE). The tissue
sections were observed under a Zeiss AxioScope.A1 Microscope
(Carl Zeiss, Germany), and images analysed using the AxioVision
digital image processing software (www.zeiss.com) for character-
isation of histopathological changes (Dixon et al., 1996); using the
following criteria: haemorrhagic damage (score: 0–4); oedema in
the upper mucosa (score: 0–4); loss of epithelial cells (score: 0–4);
haemorrhagic injury (score: 0–4), and the presence of leucocytes
(score: 0–4).
2.12. Anti-Helicobacter pylori activity
The activity of SIECm against H. pylori was investigated usingbroth Microdilution assay (McNulty, 2002). BHI broth (100 mL per
well) supplemented with 10% foetal bovine serum was inoculated
with 6108H. pylori (McFarland turbidity standard 2). The serial
dilutions (Eppendorf Xplorers Plus, Hamburg, Germany) of the ex-
tract dissolved in 0.04% DMSO (100 mL), and BHI was added to each
well in the microplate, to reach ﬁnal concentrations of 6.25–
800 mg/mL. Clarithromycin (0.195–50 mg/mL) was used as the stan-
dard drug. The microplate was then incubated at 37 °C under mi-
croaerophilic conditions in an atmosphere of 5–15% O2 and 5–10%
CO2, for 4 days. The optical density of the turbidity was measured at
450 nm using a microplate reader. Tests were performed in duplicate
and activity assessed based on the criteria for antimicrobial activity of
plant extracts. The activity of the extract against the microorganisms
was classiﬁed as having a good antimicrobial activity
MICr100 mg/mL; moderate 100oMICo500 mg/mL; weak
500oMICo1000 mg/mL weak; and inactive MICZ1000 mg/mL
(Holetz et al., 2002).
2.13. Data analysis
The results were expressed as mean7standard error of mean.
Parametric one way-analysis of variance (ANOVA) was used to
compare the means between groups, followed by the Student–
Newman–Keuls test for multiple comparisons using GraphPad
Prism Version 5.01 software for Windows (San Diego California,
USA). In the case of non-parametric measures, comparisons were
made using Kruskal-Wallis test followed by Dunn’s test. The in-
hibition concentrations 50% (IC50) were determined from a linear
regression curve relating the percentage of inhibition vs. the
logarithm of the tested concentrations and assuming a conﬁdence
level of 99% (po0.01) for the curve obtained. For in vitro assays
that do not involve statistical analysis, we used the mean7SEM of
three independent experiments performed in duplicate.3. Results
3.1. Qualitative phytochemical constituents
The qualitative phytochemical test of SIECm using the TLC
technique detected mainly phenolics, ﬂavonoids and phytosterols
as the major constituents. The main components and distinct re-
tention factor (Rf) observed were as shown in Fig. 1.
3.2. HPLC ﬁngerprints
The analysis by HPLC conﬁrmed the qualitative TLC test with
regard to the presence of the main phytochemical constituents. In
a working time of 37 min, compounds matrixes in SIECm were
detected in the intervals between 10 and 31 min. The data show
the presence of (peak number,: Retention time): Gallic acid
(1,:10.10 min), rutin (16,: 24.88 min), ellagic acid (17,: 25.47 min),
catechin (19,: 26.10 min), and quercetin (20,: 27.77 min) as shown
in Fig. 2.
3.3. Quantitative phytochemical analysis
The contents of total phenolics, ﬂavonoids and phytosterol in
SIECm were: 148.1171.5 mg GAE/g; 67.0770.28 mg RE/g and
192.1072.26 mg SE/g respectively.
3.4. Cytotoxicity assay
The result showed that SIECm did not alter the cellular viability of
CHO-k1 cells' line’s ability to reduce Alamar blue, with IC50
value4200 mg/mL after both 24 h and 72 h exposure. The standard
Fig. 1. TLC proﬁles of infusion extract of the leaves of Copaifera malmei (SIECm) under UV camera at 365 nm; revealed using NP/PEG (A), and Citroboric (B).
Fig. 2. HPLC ﬁngerprints of infusion extract of the leaves of Copaifera malmei (SIECm) showing a total of 24 peaks due to metabolic classes in the extract or their synergistic
interactions.
B. Adzu et al. / Journal of Ethnopharmacology 175 (2015) 378–389 383agent used (doxorubicin) gave an IC50 value458 mg/mL at 24 h, which
was highly cytotoxic at 72 h with IC50¼0.370.04 mg/mL.
3.5. Acute toxicity test
SIECm at 5000 mg/kg, p.o. showed no signiﬁcant alteration in
behaviour. There was no signiﬁcant difference in the weight gain,
and none of the mice died throughout the 14 day duration test/
observation period.
3.6. Acidiﬁed ethanol-induced gastric ulcers
The acidiﬁed ethanol caused severe gastric ulceration as ex-
pected in the vehicle control group (6.14%). Treatment with SIECminhibited the gastric lesions induced by the ulcerogenic agent dose
dependently with maximal inhibition of 71.28% (po0.01) at
400 mg/kg. The standard drug used (carbenoxolone, 100 mg/kg) in
this model inhibited the induced ulceration by 74.92% (po0.01) as
shown in Fig. 3.
3.7. Piroxicam-induced gastric ulcer
Piroxicam induced gastric ulceration was characterized by
mucosal haemorrhage in the gastric body and antrum, and was
signiﬁcantly attenuated by treatment with SIECm in all the doses
tested, with 400 mg/kg of the extract producing a comparable
effect (80%; po0.001) with the standard drug used (ranitidine
50 mg/kg, p.o.) which caused 90% (po0.001) inhibition (Table 1).
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Fig. 3. Effect of oral administration of vehicle (10 mL/kg), infusion extract of the
leaves of Copaifera malmei (SIECm; 25, 100 and 400 mg/kg) and carbenoxolone
(Cbx, 100 mg/kg) against acidiﬁed ethanol-induced gastric lesion in mice. Each bar
represent mean7SEM, n¼6; one-way analysis of variance (ANOVA), followed by
Student–Newman–Keuls test for multiple comparison. *po0.05; and **po0.01 vs.
vehicle.
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Fig. 4. Effect of oral administration of vehicle (10 mL/kg, p.o.), infusion extract of
the leaves of Copaifera malmei (SIECm; 25, 100 and 400 mg/kg, p.o.) and cimetidine
(Cimet, 100 mg/kg, p.o.) on water restrained stress-induced gastric lesion in rats
(WRS). Each column represent mean7SEM, n¼6; one-way ANOVA, followed by
Student-Newman–Keuls test for multiple comparison. ***po0.001 vs. vehicle.
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Subjecting the rats toWRS caused gastric bleeding char-
acterised by the mucosal haemorrhage and lesions; with an ul-
cerated area of 8.73 mm2 in the vehicle control group. Oral ad-
ministration of SIECm (25, 100 and 400 mg/kg) signiﬁcantly in-
hibited the ulcerative lesions dose dependently, with maximal
inhibition of 57.91% (p o0.001) at 400 mg/kg. The standard drug
(cimetidine, 100 mg/kg) gave a superior activity with 92.28%
(po0.001) inhibition, compared to the vehicle group, as seen in
Fig. 4.
3.9. Acetic acid induced-chronic ulcer
The surgically induced acetic acid chronic ulcer caused ul-
ceration in the mice, with the vehicle group presenting an ul-
ceration of 8.7971.14 mm2. The post-operative treatment with
SIECm for 7 days, accelerated healing of the induced chronic ul-
ceration with a peak effect at 200 mg/kg (62.00%; po0.001), si-
milar to the standard drug cimetidine (50 mg/kg) (69.74%;
po0.001) when compared to the vehicle control group (Table 2).
3.10. Effect on gastric secretion
Table 3 shows the results of the effect of vehicle, SIECm (12.5,
50 and 200 mg/kg) and cimetidine (50 mg/kg) on the secretoryTable 1
Effect of orally administered vehicle (10 mL/kg), infusion extract of the leaves of
Copaifera malmei (SIECm; 25, 100 and 400 mg/kg), ranitidine (50 mg/kg) on pir-
oxicam induced gastric ulcer in rats.
Treatment Dose (mg/kg) Ulcerated area (mm2)a % Inhibition
Vehicle – 15.2570.14 –
SIECm 25 10.0270.04 34.30n
100 6.9470.05 54.49nn
400 2.9170.02 80.91nnn
Ranitidine 50 1.4270.01 90.69nnn
a Each value represents mean7SEM, n¼6 animals; one-way ANOVA, followed
by Student–Newman–Keuls test for multiple comparison.
n po0.05.
nn po0.01.
nnn po0.001 vs. vehicle.parameters in rats with pylorus ligation. SIECm (12.5, 50 and
200 mg/kg) signiﬁcantly reduced the volume of gastric secretion
in a dose-dependent manner, with maximal inhibition of 75.10%
(po0.001) for 200 mg/kg; while cimetidine (50 mg/kg) inhibited
the secretion of gastric juice by 79.82% (po0.001) when compared
with the vehicle group. A signiﬁcant increase (67.93%, po0.05) in
the free acidity (pH) was observed only at the dose of 200 mg/kg
of SIECm when compared with the vehicle group
(pH¼2.3770.26), while the reference drug (cimetidine) inhibited
the pH by 82.92%. In the case of total acidity, reduction were ob-
served as a result of treatment with SIECm (50 and 200 mg/kg)
and cimetidine (50 mg/kg) by 26.15% (po0.05), 43.13 and 54.50%
(po0.01), respectively.3.11. Protective effect on gastric barrier mucus
The administration of acidiﬁed ethanol caused a 56.26%
(po0.001) reduction in the gastric mucus as shown by the dye
recovery compared to the sham group. Treatment with SIECm
prevented the gastric mucus depletion at doses of 100 (po0.05)
and 400 mg/kg (po0.001) compared to the vehicle control group.
For 100 mg/kg of carbenoxolone, reduction in the depletion was
slightly higher (69.04%, po0.01) than observed in the highest
dose of the SIECm (Fig. 5).Table 2
Effect of oral administration of the vehicle (10 mL/kg), infusion extract of the leaves
of Copaifera malmei (SIECm; 12.5, 50 and 200 mg/kg) and cimetidine (50 mg/kg) on
the gastric ulcers induced by acetic acid in mice.
Treatment Dose (mg/kg)a Ulcerated area (mm2)b % Cure rate
Vehicle – 8.7971.14 –
SIECm 12.5 4.0970.35 53.47nn
50 3.5270.50 59.95nnn
200 3.3470.23 62.00nnn
Cimetidine 50 2.6670.37 69.74nnn
a Twice daily7 days.
b Each value represents the mean7S.E.M. 6 animals per group; One-way AN-
OVA, followed by the Student–Newman–Keuls test.
nn po0.01.
nnn po0.001 vs. vehicle.
Table 3
Effect of intraduodenal (id.) administration of vehicle 10 mL/kg, infusion extract of
the leaves of Copaifera malmei (SIECm; 12.5, 50 and 200 mg/kg) and cimetidine
(50 mg/kg) on gastric secretion on the pylorus-ligation-induced ulcers in rats.
Treatment Dose
(mg/kg,
id.)
Gastric volume
(mL)
Free acidity (pH) Total acidity (mEq
[Hþ]/mL)
Vehicle – 4.6670.85 2.3770.26 12.3170.80
SIECm 12.5 3.0770.48n 2.8970.37 10.2470.78
50 2.1970.67nnn 3.1470.27 9.0970.37n
200 1.1670.18nnn 3.9870.59n 7.0070.68nnn
Cimetidine 50 0.9470.18nnn 6.4470.32nn 5.6070.43nnn
Each value represents mean7SEM, n¼6; one-way ANOVA, followed by Student-
Newman–Keuls test for multiple comparison.
n po0.05.
nn po0.01.
nnn po0.001 vs. vehicle. Vehicle 25 100 Cbx Veh + 25 + 100 + Cbx+
0
5
10
15
Acidified ethanol
L-NAME (10 mg/kg)
**
++
   Saline
      #
++
**U
lc
er
at
ed
 a
re
a 
(%
)
SIECmSIECm
Fig. 6. Effect of pre-treatment with L-NAME (10 mg/kg) on gastric damage, and on
gastroprotective effect of infusion extract of the leaves of Copaifera malmei (SIECm;
25, and 100 mg/kg) and carbenoxolone (Cbx, 30 mg/kg). Each column represents
the mean7S.E.M. of 5–6 animals. One-way ANOVA followed by Student-Newman-
Keuls test. ** po0.01 vs. vehicle; þþ po0.01 vs. control values; #po0.05 vs. Cbx.
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SIECm
Pre-treatment with L-NAME to evaluate the role of NO pro-
duction in SIECm gastroprotection, showed that it inhibited
(po0.001) the induced increments in the ethanol-induced gastric
mucosal lesions by L-NAME. As expected, the gastroprotection of
carbenoxolone was also partially attenuated (po0.05) when
compared to its respective control group (Fig. 6).3.13. Catalase activity
Analysis revealed an increased in catalase enzymatic activity in
the vehicle by 83.34% (po0.001) compared to the sham group.
Treatment with SIECm prevented the deleterious increase in the
catalase activity dose-dependently, with maximum effect being
66.14% (po0.01). Cimetidine also confers similar protection, in-
hibiting by 72.62% (po0.01) as shown in Fig. 7.Sham Vehicle 25 100 400 Cbx 100 
0
50
100
150
200
mg/kg
Acidified ethanol
SIECm
     ***
*
       ###
 ***
Al
ci
an
 b
lu
e 
(u
g/
g 
tis
su
e)
Fig. 5. Effect of orally administered vehicle (10 mL/kg), infusion extract of the
leaves of Copaifera malmei (SIECm; 25, 100 and 400 mg/kg) and carbenoxolone
(Cbx, 100 mg/kg) on gastric mucus in mice with gastric ulcer induced by acidiﬁed
ethanol. Each bar is mean7SEM, n¼6 mice; one-way ANOVA, followed by Stu-
dent-Newman–Keuls test for multiple comparison. *po0.05; and ***po0.001 vs.
vehicle; ###po0.001 vs. sham.3.14. Myeloperoxidase (MPO) action
Subjecting the rats to WRS showed that the MPO action in-
creased in the vehicle group by 63.08% (po0.001) compared to
the sham. Treatment with SIECm attenuated this increase at the
doses of 100 and 400 mg/kg, with maximum effect being 38.99%
inhibition (po0.05). Cimetidine also confers similar protection,
inhibiting the increase MPO activity by 47.19% (po0.01) as shown
in Fig. 8.Sham Vehicle 25 100 400 Cimet 100 
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Fig. 7. Effect of oral administration of vehicle (10 mL/kg), infusion extract of the
leaves of Copaifera malmei (SIECm; 25, 100 and 400 mg/kg), and cimetidine (Cimet,
100 mg/kg) on the activity of catalase in rats subjected to water restrained stress
(WRS). Each column represents the mean7S.E.M. of 6 animals. One-way ANOVA
followed by Student–Newman–Keuls test. *po0.05; and ** p o0.01 vs. vehicle; ###
po0.001 vs. sham.
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Fig. 8. Effect of oral administration of vehicle (10 mL/kg), infusion extract of the
leaves of Copaifera malmei (SIECm; 25, 100 and 400 mg/kg), and cimetidine (Cimet,
100 mg/kg) on the MPO action in rats subjected to water restrained stress (WRS).
Each column represents the mean7S.E.M. of 6 animals. One-way ANOVA followed
by Student–Newman–Keuls test. *po0.05; and ** po0.01 vs. vehicle; ###po0.001
vs. sham.
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As shown in Table 4, no damage to the gastric tissue was ob-
served in the Sham group. However, the oral administration of
acidiﬁed ethanol caused a marked haemorrhagic injury, oedema,
epithelial cells loss and leucocytes inﬁltration. Treatment with
SIECm (100 and 400 mg/kg) reduced the severity of damage to the
gastric tissues by 44.82 (po0.05) and 56.90% (po0.01), respec-
tively, while the reference drug (carbenoxolone, 100 mg/kg)
caused a reduction of 67.24% (po0.01). The qualitative re-
presentative of the gastric tissue of each group is presented in
Fig. 9.
3.16. Anti-Helicobacter pylori activity
In concentrations range of 6.25–800 mg/mL, infusion extract of
the leaves of C. malmei (SIECm) showed no anti H. pylori activity.
Clarithromycin, the standard for this test showed an intense ac-
tivity with MIC of 0.78 mg/mL.4. Discussion
The phytochemical constituents' proﬁle of SIECm wasTable 4
Effect of orally administered vehicle (10 mL/kg), infusion extract of the leaves of Copaife
gastric mucus in mice with gastric ulcer induced by acidiﬁed ethanol.
Treatment (mg/kg, p.o.) Dose Haemorrhagic damage (max. 4) Oedema (m
Sham – 0 0
Vehicle – 4.00 4.00
SIECm 25 4.00 4.00
100 2.25 2.25
400 1.75 1.75
Cbx 100 1.25 1.25
Data shown are the mean scores. ANOVA of Kruskal–Wallis non-parametric test followe
n po0.05.
nn po0.01 vs. vehicle.investigated using TLC and HPLC techniques to identify relevant
secondary metabolites groups and useful chemical markers. Such
multiconstituent proﬁle markers are used for quality control of
herbal preparations and subsequent validity checks. An important
ﬁnding in the phytochemical analysis of SIECm is the presence of
phenolics, ﬂavonoids and phytosterols; which were subsequently
quantiﬁed separately using their speciﬁc assays.
Literature reports revealed that the tannins (polyphenolics) act
as haemostatic in the wound healing process, by forming a pro-
tective layer (tannin-protein/tannin-polysaccharide complex) over
the injured epithelial gastric mucosa; leading to the formation of a
coated-barrier against gastric juice and permitting the ulcer
healing process (Vasconcelos et al., 2010). Flavonoids exhibit anti-
inﬂammatory action and induce angiogenesis and cell prolifera-
tion in addition to their gastroprotective effects (Vasconcelos et al.,
2010). Sterols have been reported to have a cytoprotective effect
on the gastroduodenal mucosa (Tovey et al., 2013).
One of the toxicity tests more frequently used for the evalua-
tion of drugs and herbal extracts is tests on cell viability and cy-
totoxicity, for the fact that many drugs can cause irreversible da-
mage at the cellular level. The CHO-k1 cell lines are widely used to
screen for cytotoxic substances, and to study mechanism
(s) leading to cytotoxicity (Węsierska-Gądek et al., 2005). Our re-
sult showed that SIECm did not alter the cellular viability of CHO-
k1 cell lines ability to reduce resazurin after both 24 and 72 h
exposures. Plant extract is considered to have an active cytotoxi-
city effect if the IC50 value following incubation between 48 and
72 h is o30 mg/mL and o4 µg/mL for pure substances (Suffness
and Pezzuto, 1990). This indicates that SIECm has no cytotoxic
effect. Although SIECm is devoid of cytotoxic effect, such in vitro
assay is not enough to predict its in vivo effect (Houghton et al.,
2007). Therefore, acute toxic effect of SIECm was also evaluated
using in vivo model to afﬁrm its safety. Result showed that SIECm
is safe, with LD50 greater than 5000 mg/kg, p.o. in mice.
The SIECm gastroprotective activity was ﬁrst assessed on the
acidiﬁed ethanol-induced gastric ulcer. The ulcerogenic agent ex-
erts direct toxic effect on epithelium and solubilises the gastric
mucus (Martins et al., 2014) and is characterized by multiple
haemorrhagic streaks along the glandular part of the stomach. This
process of gastric ulceration can be blocked or successfully treated
with potent gastroprotective agent, making the model a useful
experimental tool to evaluate the capacity of a test agent in pro-
tecting the gastric mucosa (Júnior et al., 2014). SIECm effectively
protects against gastric ulceration in this model and thus de-
monstrate its potential as a gastroprotective agent.
Induction of gastric ulcer and potentiation or impairment of the
healing of pre-existing ulcers is one of the drawbacks in the use of
NSAIDs. Our evaluation of the effect of SIECm on ulceration in-
duced by piroxicam shows that SIECm attenuated the induced
ulcerations, indicating that the extract may be acting by increasingra malmei (SIECm; 25, 100 and 400 mg/kg) and carbenoxolone (Cbx, 100 mg/kg) on
ax. 4) Epithelial damage (max 4) Leucocytes (max. 4) Total (max. 16)
0 1.00 1.00
4.00 2.50 14.50
4.00 2.25 14.25
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d by Dunn’s test.
Fig. 9. Histopathological analysis of the Sham (A); vehicle (B); infusion extract of the leaves of Copaifera malmei [SIECm, 25 (C), 100 (D), and 400 (E) mg/kg], and carbe-
noxolone (F) on gastric mucosa lesions induced by acidiﬁed ethanol in mice. The arrows indicate epithelial damage (curve arrow), vascular damage (straight arrows), and
leucocyte inﬁltration (arrowheads). Analysis of the tissue revealed normal gastric mucosa (A), extensive damages to the gastric mucosa (B), mild damage areas (C), and
signiﬁcant reduction in the epithelial damage (D, E and F). Stain: Haematoxylin and eosin. Bar¼50 mm.
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and thereby exhibiting gastroprotection through mucus produc-
tion, and/or increased blood ﬂow.
The ulcerogenic processes of the WRS is attributed to activation
of peripheral autonomic pathways, characterised by neuro-
transmitters release leading to alteration of gastric blood, stimu-
lation of gastric motility, enhanced acid secretion and reduced
mucus production (Murakami et al., 1985). The SIECm exhibited
gastroprotective activity in this model. The activity of the extract
on the model is a very important criterion to assess the extract's
potential efﬁcacy as an anti-ulcer prototype due to its pathophy-
siological similarity to human gastric ulcer (Paré, 1989).
The acetic acid ulcer model has been used to investigate gastric
ulceration and the ulcer healing efﬁcacy of drugs against the dis-
ease. The model mimics the pathophysiology of human gastric
ulcer disease in both necrosis of the gastric mucosa and its healing
process (curative mechanisms) whereby the two distinct patho-
logical characteristics: ulcer border and granulation tissue are
expressed. The SIECm caused reduction of the ulcerated area by
acetic acid at all doses tested, in a manner comparable to cimeti-
dine. This result indicates that the extract contain potent con-
stituent with gastric ulcer curative potentials (Martins et al., 2014).
The plausible mechanisms of the gastroprotective activity of
SIECm were also assessed. Currently, gastric ulcer treatment is in
two main approaches: reduction of gastric acid secretion and re-
enforcement of gastric mucosal protection, along with the eradi-
cation of H. pylori in infected patients. We tested the efﬁcacy of
SIECm in achieving these objectives.
Gastric ulceration in the pylorus-ligation model results from
auto-digestion of mucosa by secretion of gastric acids thateventually leads to the activation of the gastric proton pump (Hþ ,
Kþ-ATPase), an important factor in the genesis of ulceration. The
activity of SIECm in this assay indicates its anti-ulceration potency,
plausibly via an antisecretory mechanism through the inhibition of
Hþ , Kþ- ATPase activity. The extract exhibited signiﬁcant activity
on the model suppressing the accumulation of: gastric juice, free
acidity (pH), and total acidity (mEq [Hþ]/mL). This effect is im-
portant since suppression of gastric acid remains the main ther-
apeutic approach to promote ulcer healing.
The gastric barrier mucus plays an important role as a ﬁrst line
defence against gastrointestinal damage. Ulcerogenic substances
cause dissipation of the mucus gel and phospholipid layer, leading
to mucosal injury. Histological dye has been used to explore the
effects of treatments on the gastric barrier mucus based on the
principle that a reduction in dye recovery indicates depletion of
mucus barrier (Corne et al., 1974). As seen from the result, the
gastroprotective effect of SIECm involves stimulation of gastric
mucus production/protection.
The gastric lesions induced by the acidiﬁed ethanol model are
also known to be associated with the reduction of endogenous
derived NO level in the gastric mucosa. This subsequently deprived
the NO role as one of the endothelial mediators essential for
mucosal defence against acute damage by decreasing gastric mu-
cosal blood ﬂow and gastric mucus secretion (Tarnawski et al.,
2012; Júnior et al., 2014). The partial attenuation of SIECm gas-
troprotective effect by L-NAME suggests that replenishment of NO
levels in the gastric mucosa by the SIECm is one of the possible
gastroprotective mechanisms of action.
The generation of free radicals are actively involved in the pa-
thogenesis of gastric ulcers, particularly when its production
B. Adzu et al. / Journal of Ethnopharmacology 175 (2015) 378–389388overwhelms the endogenous anti-oxidant system. We thus eval-
uated the antioxidant effect of SIECm. Our ﬁnding shows that
SIECm curtailed the excessively elevated catalase activity, and
decreased the MPO action in the WRS. This indicates that the
gastroprotection effect of the SIECm is partly due to its antioxidant
action.
Histopathological evaluation showed that SIECm caused re-
duction or prevention of epithelial and vascular damage, and
leucocyte inﬁltration. Contraction of ﬁbrous tissue formed at ulcer
sites by ﬁbroblast (cicatrisation) that leads to the ulcer healing
process is performed by undifferentiated epithelial precursors that
migrates from the ulcer border to the granulation tissue and
eventually covering the base of the ulcer (Vasconcelos et al., 2010).
The reduction/prevention of epithelial cell loss as conﬁrmed by
histological analysis is an indication of its potent anti-ulcer
activity.
In conclusion, the study demonstrated that the SIECm has low
oral acute toxicity, and exhibited gastroprotective and ulcer heal-
ing effect. This justiﬁes the folkloric use of C. malmei leaves infu-
sion in the treatment of gastric ulcers and also provided scientiﬁc
evidence for the plant’s potential as an anti-ulcer drug prototype.
The mechanism in which SIECm exerts these effects is multi-tar-
geted: plausibly mediated by complementary effects of protection/
production of the gastric mucus, inhibition of gastric juice secre-
tion, positive modulation of NO production and antioxidant effect.
These gastroprotective activities might be attributed to the phy-
tochemicals detected in the plant extracts, most likely acting as
moiety (synergistically). The extract, however might have a lim-
itation in cases in which H. pylori is the main aetiological factor
since our results showed that SIECm was inactive against the
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